e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Advances in asthma pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of endocannabinoid metabolism inhibition on airway inflammation in mice
R. Abohalaka (Ankara, Turkey), T. Bozkurt (Ankara, Turkey), E. Nemutlu (Ankara, Turkey), S. Onder (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey)
Source:
International Congress 2019 – Advances in asthma pharmacology
Session:
Advances in asthma pharmacology
Session type:
Poster Discussion
Number:
3878
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Abohalaka (Ankara, Turkey), T. Bozkurt (Ankara, Turkey), E. Nemutlu (Ankara, Turkey), S. Onder (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey). The effect of endocannabinoid metabolism inhibition on airway inflammation in mice. 3878
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Sirtuins inhibition modulates endotoxin-induced lung inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
The protective effects of SIGIRR on flagellin-induced acute inflammation of the airway in mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice
Source: Eur Respir J 2015; 46: 1451-1460
Year: 2015
Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 575s
Year: 2007
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production
Source: Eur Respir J 2002; 20: Suppl. 38, 382s
Year: 2002
Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
Role of Clara cell protein (CC)- 10 in the regulation of allergic airway inflammation and tolerance induction in mice
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Effects of dehydrodieugenol on neuroinflammation and behavior changes in mice with mixed granulocytic chronic airway inflammation
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept